Cellular and RAS changes in the hearts of young obese rats

Kee Soo Ha1, Kee Hwan Yoo, Hyung Eun Yim

  • 1Department of Pediatrics, College of Medicine, Korea University, Seoul, South Korea.

Pediatric Cardiology
|March 25, 2011
PubMed

Insights

Childhood obesity in rats led to heart septal thickening and increased cell turnover. Renin and angiotensin II type 2 receptor (AT2R) levels rose, suggesting a protective effect against obesity-induced heart changes.

Area of Science:

  • Cardiology
  • Pediatric Obesity
  • Renin-Angiotensin System

Background:

  • Childhood obesity is a risk factor for adult cardiovascular diseases.
  • Understanding early cardiac changes in obesity is crucial for prevention.
  • The renin-angiotensin system's role in pediatric obesity-related cardiac dysfunction requires further investigation.

Purpose of the Study:

  • To investigate the cellular and renin-angiotensin system alterations in the heart of young obese rats.
  • To assess the impact of early-onset obesity on cardiac structure and function.

Main Methods:

  • Sprague-Dawley rats were used, with early obesity induced by pup overfeeding.
  • Assessments included body weight, heart weight, blood pressure, serum glucose, echocardiography, PCNA, apoptosis, Masson's trichrome staining, and Western blotting.
  • Comparisons were made between normal litter (NL) and small litter (SL, obesity) groups.

Main Results:

  • Obese rats (SL) showed a 61.2% increase in body weight and increased interventricular septal thickness.
  • Hyperplasia of proliferating cell nuclear antigen (PCNA) positive cells and increased apoptosis were observed, without cellular hypertrophy or altered collagen.
  • Western blotting revealed increased renin and angiotensin II type 2 receptor (AT2R), with no change in angiotensin II type 1 receptor (AT1R).

Conclusions:

  • Early-onset obesity in rats induces echocardiographically detected septal hypertrophy and increased cellular turnover.
  • Renin and AT2R are upregulated in the obese rat heart, while AT1R remains unchanged.
  • The upregulation of AT2R may represent a cardioprotective mechanism against early obesity-induced cardiac pathology.